華夏文化科技(01566.HK)經審核全年業績押後至9月15日刊發
華夏文化科技(01566.HK)公布,經審核截至今年3月底止年度業績的預期刊發日期及集團年度報告的預期寄發日期,料將押後至9月15日。
公司指出,由於疫情爆發持續對上海造成影響,而公司其中一家營運上海Joypolis的主要附屬正位於上海,相關的疫情限制措施持續阻礙公司核數師進行審核程序。基於上述的審核程序延遲,由集團專業專家編製的減值模型評估;連同數據輸入及假設的相關估值;及就清盤呈請對按持續經營基準編製財務報表造成的影響進行的有關檢討及評估,均需押後至審核程序完成為止。目前,審核程序仍未完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.